JP2024540318A5 - - Google Patents

Info

Publication number
JP2024540318A5
JP2024540318A5 JP2024526654A JP2024526654A JP2024540318A5 JP 2024540318 A5 JP2024540318 A5 JP 2024540318A5 JP 2024526654 A JP2024526654 A JP 2024526654A JP 2024526654 A JP2024526654 A JP 2024526654A JP 2024540318 A5 JP2024540318 A5 JP 2024540318A5
Authority
JP
Japan
Prior art keywords
cyclohexyl
carboxamide
imidazole
compound
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024526654A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024540318A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2022/052833 external-priority patent/WO2023084206A1/en
Publication of JP2024540318A publication Critical patent/JP2024540318A/ja
Publication of JP2024540318A5 publication Critical patent/JP2024540318A5/ja
Pending legal-status Critical Current

Links

JP2024526654A 2021-11-09 2022-11-09 Cd38阻害剤としてのn-(4-アミノシクロヘキシル)ピリミジン-4-カルボキサミド誘導体 Pending JP2024540318A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2116077.5 2021-11-09
GB202116077 2021-11-09
PCT/GB2022/052833 WO2023084206A1 (en) 2021-11-09 2022-11-09 N-(4-aminocyclohexyl)pyrimidine-4-carboxamide derivatives as cd38 inhibitors

Publications (2)

Publication Number Publication Date
JP2024540318A JP2024540318A (ja) 2024-10-31
JP2024540318A5 true JP2024540318A5 (cg-RX-API-DMAC7.html) 2025-11-18

Family

ID=84360092

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024526654A Pending JP2024540318A (ja) 2021-11-09 2022-11-09 Cd38阻害剤としてのn-(4-アミノシクロヘキシル)ピリミジン-4-カルボキサミド誘導体

Country Status (6)

Country Link
US (1) US20250019369A1 (cg-RX-API-DMAC7.html)
EP (1) EP4430034A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024540318A (cg-RX-API-DMAC7.html)
CN (1) CN118317955A (cg-RX-API-DMAC7.html)
CA (1) CA3236793A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023084206A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4532483A1 (en) * 2022-06-02 2025-04-09 Aeovian Pharmaceuticals, Inc. Cd38 modulators and uses thereof
EP4724430A1 (en) * 2023-06-07 2026-04-15 Flagship Pioneering Innovations VI, LLC Condensed azines as inhibitors of cyclic adp ribose hydrolase
WO2026000074A1 (en) * 2024-06-25 2026-01-02 Welnx Company Inc. Use of cd38 inhibitors for reducing th2 inflammation
WO2026075971A1 (en) 2024-10-01 2026-04-09 Neolaia Inc. Combination therapy for treatment of metabolic disorders and inflamation related disorders using incretin compounds and cd38 inhibitors
WO2026090857A1 (zh) * 2024-10-29 2026-05-07 甫康(上海)健康科技有限责任公司 一种多取代的氨基喹啉类化合物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11535621B2 (en) 2019-07-31 2022-12-27 Ribon Therapeutics, Inc. Heterobicyclic amides as inhibitors of CD38
KR20230051425A (ko) * 2020-04-07 2023-04-18 미토브리지, 인크. Cd38 억제제
CN117715897A (zh) * 2021-04-30 2024-03-15 南京艾美斐生物医药科技有限公司 化合物及其作为cd38抑制剂的用途

Similar Documents

Publication Publication Date Title
DE60005560T2 (de) Neuartiger p2x 7 rezeptor-antagonisten zur verwendung in der behandlung von entzündlichen, immuninduzierten erkrankungen oder erkrankungen des herz-kreislauf-systems
JP2006526617A5 (cg-RX-API-DMAC7.html)
US9688629B2 (en) Indole carboxamide compounds
JP2010518026A5 (cg-RX-API-DMAC7.html)
JP6254075B2 (ja) カリウムチャネル遮断剤としてのアミン誘導体
CA3224467A1 (en) Phenyl acetamide based il-17a modulators and uses thereof
WO1999019301A1 (en) Piperazine compounds and medicinal use thereof
TW201609706A (zh) 胺基嘧啶基化合物
JP2011063620A (ja) ピペリジンおよびピペラジン誘導体
JPWO1999019301A1 (ja) ピペラジン化合物およびその医薬としての用途
HRP20180973T1 (hr) Supstituirani tiazolski ili oksazolski antagonisti p2x7 receptora
JP2018522925A5 (cg-RX-API-DMAC7.html)
JP2010524907A (ja) トリアゾロピリジンカルボキサミド誘導体、その調製およびその治療的使用
TWI687396B (zh) N-[4-(1-胺基乙基)苯基]磺醯胺衍生物掌性解析之方法
IL279920B2 (en) Bicyclic inhibitors of histone deacetylase
JP2022550881A (ja) N-(1h-イミダゾール-2-イル)ベンズアミド化合物および該化合物を活性成分として含む医薬組成物
US20140350250A1 (en) Therapeutic agent for cerebral infarction
WO2017119666A1 (ko) 극성 비양자성 용매를 이용한 n-[4-(1-아미노에틸)-페닐]-술폰아미드 유도체의 카이랄 분할 방법
JP2025506729A5 (cg-RX-API-DMAC7.html)
JP2009520000A (ja) カンナビノイドcb1受容体モジュレーターとしての4,5−ジヒドロ−(1h)−ピラゾール誘導体
JP2023538325A5 (cg-RX-API-DMAC7.html)
JP2023507508A5 (cg-RX-API-DMAC7.html)
EP4538259A1 (en) Processes for the preparation of deucravacitinib
JP2008019168A (ja) 2−シアノ−4−フルオロピロリジン誘導体の製造法
JP2009185008A (ja) グリシントランスポーター阻害活性を有する化合物